Search Results

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“Miravo” or the “Company”) and Searchlight Pharma Inc., a private Canadian-based specialty healthcare company (“Searchlight”), are pleased to announce the closing of the previously announced plan of arrangement (the “Arrangement”) of Miravo with Searchlight.

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) reminds its shareholders (“ Shareholders ”) of its special meeting of Shareholders (the “ Meeting ”) to be held virtually on March 7, 2023.

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare is pleased to announce that, its shareholders voted in favour of a special resolution to approve the previously announced plan of arrangementpursuant to which, among other things, Searchlight Pharma Inc. will acquire all of the Company shares.

Miravo Healthcare ™ Announces Second Quarter 2022 Results.

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare announced that it has filed and is in the process of mailing the management information circular and related materials in connection with the special meeting of its shareholders to be held virtually on March 7, 2023.

Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare today announced its financial and operational results for the three and nine months ended September 30, 2022.

Miravo Healthcare ™ Announces Appointment of Anthony Snow to its Board of Directors.

Nuvo Pharmaceuticals ® Inc. today announced Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the Bloom Burton & Co. Healthcare Investor Conference.

Miravo Healthcare ™ Announces First Quarter 2022 Results.

Miravo Healthcare™ Announces Second Quarter 2022 Results Release Date and Conference Call Details.